Jazz Pharmaceuticals (JAZZ) PT Lowered to $129 at Piper Sandler
Tweet
Share
E-mailGet Alerts JAZZ Hot Sheet
Price: $245.85 -1.25%
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
33 Buy, 5 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Piper Sandler analyst David Amsellem lowered the price target on Jazz Pharmaceuticals (NASDAQ: JAZZ) to $129.00 (from $142.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Jazz Pharmaceuticals (JAZZ) PT Raised to $283 at Morgan Stanley
- Lotes Co Ltd (3533:TT) PT Lowered to NT$2,720 at Nomura/Instinet
- Tata Motors Passenger Vehicles (TMPV:IN) PT Raised to INR389 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
